Profile | GDS2987 / GI_13376530-S |
Title | Comparison of Rho kinase inhibitor and atorvastatin effects on primary cell lines |
Organism | Homo sapiens |
Sample | Title | Value | Rank |
---|---|---|---|
GSM214810 | HMVEC_vehicle_rep1 | ||
GSM215244 | HMVEC_vehicle_rep2 | ||
GSM215253 | HMVEC_vehicle_rep3 | 12.1 | 38 |
GSM215254 | HMVEC_atorvastatin_rep1 | ||
GSM215282 | HMVEC_atorvastatin_rep3 | ||
GSM215344 | HMVEC_atorvastatin_rep2 | 6.6 | 17 |
GSM215283 | HMVEC_atorvastatin_mevalonate_rep1 | ||
GSM215284 | HMVEC_atorvastatin_mevalonate_rep2 | 18.8 | 36 |
GSM215293 | HMVEC_atorvastatin_mevalonate_rep3 | 2.2 | 4 |
GSM215294 | HMVEC_SLx2119_rep1 | ||
GSM215295 | HMVEC_SLx2119_rep2 | 4.7 | 10 |
GSM215296 | HMVEC_SLx2119_rep3 | 30.9 | 46 |
GSM215297 | PASMC_vehicle_rep1 | 50.5 | 59 |
GSM215298 | PASMC_vehicle_rep2 | 14.2 | 22 |
GSM215310 | PASMC_vehicle_rep3 | 18.3 | 29 |
GSM215311 | PASMC_atorvastatin_rep1 | 32.1 | 49 |
GSM215312 | PASMC_atorvastatin_rep2 | 18.7 | 29 |
GSM215313 | PASMC_atorvastatin_rep3 | 22.3 | 32 |
GSM215324 | PASMC_atorvastatin_mevalonate_rep1 | ||
GSM215325 | PASMC_atorvastatin_mevalonate_rep2 | 9.8 | 20 |
GSM215326 | PASMC_atorvastatin_mevalonate_rep3 | ||
GSM215327 | PASMC_SLx2119_rep1 | 6.9 | 13 |
GSM215328 | PASMC_SLx2119_rep2 | 21.5 | 37 |
GSM215329 | PASMC_SLx2119_rep3 | 7.5 | 15 |
GSM215330 | Fibroblasts_vehicle_rep1 | 17.9 | 39 |
GSM215331 | Fibroblasts_vehicle_rep2 | 11.7 | 32 |
GSM215332 | Fibroblasts_vehicle_rep3 | 15.2 | 45 |
GSM215333 | Fibroblasts_atorvastatin_rep1 | ||
GSM215334 | Fibroblasts_atorvastatin_rep2 | 5.6 | 16 |
GSM215335 | Fibroblasts_atorvastatin_rep3 | ||
GSM215336 | Fibroblasts_atorvastatin_mevalonate_rep1 | 17.2 | 49 |
GSM215337 | Fibroblasts_atorvastatin_mevalonate_rep2 | 11.9 | 36 |
GSM215338 | Fibroblasts_atorvastatin_mevalonate_rep3 | 4.6 | 13 |
GSM215339 | Fibroblasts_SLx2119_rep1 | 15 | 41 |
GSM215340 | Fibroblasts_SLx2119_rep2 | 8.6 | 24 |
GSM215341 | Fibroblasts_SLx2119_rep3 |